reglab/housing_qa huggingface dataset:
AR Code § 20-7-608 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-608. Information exchange with other prescription drug monitoring programs

 (a) The Department of Health may provide prescription monitoring information to federal prescription drug monitoring programs or other states' prescription drug monitoring programs, and the information may be used by those programs consistent with this subchapter.  (b) The department may request and receive prescription monitoring information from federal prescription drug monitoring programs or other states' prescription drug monitoring programs and may use the information under this subchapter.  (c) The department may develop the capability to transmit information to other prescription drug monitoring programs and receive information from other prescription drug monitoring programs employing the standards of exchangeability.  (d) The department may enter into written agreements with federal prescription drug monitoring programs or other states' prescription drug monitoring programs for the purpose of describing the terms and conditions for sharing prescription information under this subchapter.
AR Code § 20-7-609 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-609. Authority to contract

 (a) The Department of Health may contract with another agency of this state or with a private vendor, as necessary, to ensure the effective operation of the Prescription Drug Monitoring Program.  (b) A contractor shall be bound to comply with the provisions regarding confidentiality of prescription information as outlined in this subchapter and shall be subject to the penalties specified in this subchapter for unlawful acts.
AR Code § 20-7-610 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-610. Authority to seek funding

 (a) The Department of Health may make application for, receive, and administer grant funding from public or private sources for the development, implementation, or enhancement of the Prescription Drug Monitoring Program.  (b) A fee shall not be levied against practitioners for the purpose of funding or complying with the Prescription Drug Monitoring Program.
AR Code § 20-7-611 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-611. Unlawful acts and penalties

 (a)  (1) It is unlawful for a dispenser to purposely fail to submit prescription monitoring information as required under this subchapter.  (2) A violation of subdivision (a)(1) of this section is a Class B misdemeanor.    (b)  (1) It is unlawful for a dispenser to purposely submit fraudulent prescription information.  (2) A violation of subdivision (b)(1) of this section is a Class D felony.    (c)  (1) It is unlawful for a person authorized to receive prescription monitoring information to purposely disclose the information in violation of this subchapter.  (2) A violation of subdivision (c)(1) of this section is a Class C felony.    (d)  (1) It is unlawful for a person authorized to receive prescription drug monitoring program information to use such information in a manner or for a purpose in violation of this subchapter.  (2) A violation of subdivision (d)(1) of this section is a Class C felony.    (e)  (1) It is unlawful for a person to knowingly obtain, use, or disclose or attempt to obtain, use, or disclose information by fraud or deceit from the Prescription Drug Monitoring Program or from a person authorized to receive information from the Prescription Drug Monitoring Program under this subchapter.  (2) A violation of subdivision (e)(1) of this section is a Class C felony.    (f) In addition to the criminal penalties provided in this section, a dispenser or practitioner who uses or discloses confidential information received from the Prescription Drug Monitoring Program in a manner or for a purpose in violation of this subchapter may be subject to disciplinary action by the dispenser's or practitioner's licensing board.  (g) In addition to the criminal penalties provided in this section, a law enforcement officer who uses or discloses confidential information received from the Prescription Drug Monitoring Program in a manner or for a purpose in violation of this subchapter may be subject to disciplinary action by the law enforcement officer's agency or department.  (h) This subchapter does not limit a person whose privacy has been compromised unlawfully under this section from bringing a civil action to address the breach of privacy or to recover all damages to which the person may be entitled per violation, including attorney's fees and costs.  (i) A practitioner who purposely fails to access the Prescription Drug Monitoring Program as required by § 20-7-604(d) is subject to disciplinary action by the licensing board of the practitioner.
AR Code § 20-7-612 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-612. Privacy rights protected

 This subchapter does not give authority to any person, agency, corporation, or other legal entity to invade the privacy of any citizen as defined by the General Assembly, the courts, or the United States Constitution or the Arkansas Constitution other than to the extent provided in this subchapter.
AR Code § 20-7-613 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-613. Rules

 The State Board of Health shall adopt rules to implement this subchapter.
AR Code § 20-7-614 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-614. Effective date

 (a) The Prescription Drug Monitoring Program shall become operational March 1, 2013, if full funding is available under § 20-7-610.  (b) The Secretary of the Department of Health may suspend operation of the program if adequate funding under § 20-7-610 ceases.
AR Code § 20-7-615 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 6 - Prescription Drug Monitoring Program Act|§ 20-7-615. Prescriber with a prescription drug violation

 (a) A prescriber who has been found by his or her licensing board to be in violation of a rule or law involving prescription drugs shall be required by the appropriate licensing board to register with the Prescription Drug Monitoring Program and access patient information before writing a prescription for an opioid.  (b) The licensing board, in its discretion, may remove this requirement after a period of time if the licensing board deems removal of the requirement appropriate.
AR Code § 20-7-701 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-701. Title

 This subchapter shall be known and may be cited as the “Combating Prescription Drug Abuse Act”.
AR Code § 20-7-702 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-702. Definitions

 As used in this subchapter:   (1) “Chronic nonmalignant pain” means pain requiring more than three (3) consecutive months of prescriptions for:  (A) An opioid that is written for more than the equivalent of ninety (90) tablets, each containing five milligrams (5 mg) of hydrocodone;  (B) A morphine equivalent dose of more than fifteen milligrams (15 mg) per day; or  (C) In the specific case of tramadol, an average dose equivalent of two hundred milligrams (200 mg) or greater per day;    (2) “Hospital” means a healthcare facility licensed as a hospital by the State Board of Health under § 20-9-213;  (3) “Opioid” means a drug or medication that relieves pain, including without limitation:  (A) Codeine;  (B) Fentanyl;  (C) Heroin;  (D) Hydrocodone;  (E) Morphine; and  (F) Oxycodone; and    (4) “Prescriber” means a practitioner or other authorized person who prescribes a Schedule II, III, IV, or V controlled substance.
AR Code § 20-7-703 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-703. Opioid prescribing guidelines for emergency department

 (a) A hospital with an emergency department shall adopt guidelines concerning opioid prescribing in the emergency department.  (b) The guidelines shall be drafted jointly by the emergency department physicians and medical staff and approved by the governing body of the hospital.  (c) The guidelines shall address, at a minimum:  (1) Treatment of chronic nonmalignant pain and acute pain;  (2) Limits on amounts or duration of opioid prescriptions; and  (3) Identification of situations where opioid prescriptions should be discouraged or prohibited.    (d) The guidelines shall not be construed as establishing a standard of care.
AR Code § 20-7-704 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-704. Prescriber education

 (a)  (1) Within the first two (2) years of being granted a license in the state, a prescriber shall obtain a minimum of two (2) hours of prescribing education approved by the appropriate licensing board.  (2) The education approved by the appropriate licensing board under subdivision (a)(1) of this section shall include:  (A) Options for online and in-person programs; and  (B) Information on prescribing rules, regulations, and laws that apply to individuals who are licensed in the state.      (b) This section shall apply to all prescribers licensed after December 31, 2015.
AR Code § 20-7-705 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-705. Licensing board rules

 (a) A licensing board that licenses individuals with prescriptive authority shall adopt rules that are at least as stringent as the rules of the Arkansas State Medical Board concerning use of narcotics for the treatment of pain not associated with malignant or terminal illness.  (b) A licensing board that licenses individuals who are authorized to prescribe opioids for treatment of chronic nonmalignant pain shall promulgate rules that contain, at a minimum, the requirements of § 20-7-707.
AR Code § 20-7-706 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-706. Patient evaluation

 A patient who is being treated with controlled substances for chronic nonmalignant pain shall be evaluated at least one (1) time every six (6) months by a physician who is licensed by the Arkansas State Medical Board.
AR Code § 20-7-707 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-707. Prescriber requirements

 (a) For a patient with chronic nonmalignant pain, a prescriber, at a minimum and in addition to any additional requirements of the appropriate licensing board, shall:  (1) Check the prescriptive history of the patient on the Prescription Drug Monitoring Program at least every six (6) months; and  (2) Have a signed pain contract with the patient that states, at a minimum, the expectations of the prescriber for the behavior of the patient which may include:  (A) A requirement for random urine drug screenings to help ensure that the patient is abiding by the requirements of the contract; and  (B) A requirement for random pill counts to ensure compliance with the prescription.      (b) The requirements of this section shall not apply to a patient:  (1) Whose pain medications are being prescribed for a malignant condition;  (2) With a terminal condition;  (3) Who is a resident of a licensed healthcare facility;  (4) Who is enrolled in a hospice program; or  (5) Who is in an inpatient or outpatient palliative care program.
AR Code § 20-7-708 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 7 - State Board of Health — Department of Health|Subchapter 7 - Combating Prescription Drug Abuse Act|§ 20-7-708. Immunity

 A prescriber or licensed healthcare facility that in good faith reports a suspected drug diversion is immune from civil or criminal liability and disciplinary action by the appropriate licensing board.
AR Code § 20-8-101 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 8 - State Health Agencies and Programs|Subchapter 1 - Health Services Permit Agency|§ 20-8-101. Definitions

 As used in this subchapter:   (1) [Repealed.]  (2) “Category of services” or “health services” means home healthcare services as defined by § 20-10-801;  (3) [Repealed.]  (4) “Conversion of services” means an alteration of the category of services offered by a health facility;  (5) [Repealed.]  (6)  (A) “Health facility” means a long-term care facility as defined by § 20-10-101 or a home healthcare services agency as defined by § 20-10-801.  (B) “Health facility” shall not mean and nothing in this subchapter shall be deemed to require a permit of approval for or to otherwise regulate in any manner the licensure of:  (i) A hospital as defined by and licensed pursuant to § 20-9-201, except when a hospital seeks to add long-term care beds or to convert acute beds to long-term care beds or to add home health services pursuant to a letter of intent filed with the Department of Health after February 15, 1993, or to expand home health services pursuant to a letter of intent filed with the department after February 15, 1993;  (ii) Offices of private physicians and surgeons;  (iii) Outpatient surgery or imaging centers;  (iv) Post-acute head injury retraining and residential care facilities or establishments operated by the United States Government or any agency thereof;  (v) Freestanding radiation therapy centers;  (vi) Expansion, not to exceed fifteen (15) beds, of the twenty-five-bed nonprofit intermediate care facility for individuals with developmental disabilities that provides transitional rehabilitation for pediatric patients;  (vii) Residences for four (4) or fewer individuals with developmental disabilities who receive support and services from nonprofit providers currently licensed by the Division of Developmental Disabilities Services;  (viii) Any facility which is conducted by and for those who rely exclusively upon treatment by prayer for healing in accordance with the tenets or practices of any recognized religious denomination; or  (ix) Any bed or facility used to provide care to delinquent juveniles committed into the care of the Division of Youth Services.    (C) “Health facility” shall not include offices of private physicians and surgeons, outpatient surgery or imaging centers, establishments operated by the United States Government or any of its agencies, freestanding radiation therapy centers, or any facility which is conducted by and for those who rely exclusively upon treatment by prayer alone for healing in accordance with the tenets or practices of any recognized religious denomination; and    (7) “Transitional rehabilitation” means rehabilitation that typically results in discharge within twenty-four (24) months after the date of admission.
AR Code § 20-8-102 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 8 - State Health Agencies and Programs|Subchapter 1 - Health Services Permit Agency|§ 20-8-102. Health Services Permit Commission — Creation — Members — Meetings

 (a) There is established the Health Services Permit Commission.  (b) The commission shall be composed of the following membership appointed by the Governor and confirmed by the Senate:  (1) A retired or practicing physician;  (2) A representative of the Department of Human Services or his or her designee;  (3) A member of the Arkansas Hospital Association, Inc.;  (4) A member of the Arkansas Health Care Association;  (5) A member of the Arkansas chapter of AARP, Inc.;  (6) A member of the HomeCare Association of Arkansas;  (7) A consumer knowledgeable in business health insurance;  (8) A member of the Arkansas Residential Assisted Living Association, Inc.; and  (9) A member of the Hospice and Palliative Care Association of Arkansas, Inc.    (c)  (1) All appointments shall be for four-year terms.  (2) No member shall be appointed to serve more than two (2) consecutive full terms.    (d) The members shall serve without pay, but those members not employed by the State of Arkansas may receive expense reimbursement in accordance with § 25-16-901 et seq.  (e) The commission shall meet at least quarterly and at such other times as necessary to carry out its duties under this subchapter. The commission shall elect one (1) of its members as chair, and by appropriate adoption of bylaws and rules, may provide for the time, place, and manner of calling its meetings.
AR Code § 20-8-103 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 8 - State Health Agencies and Programs|Subchapter 1 - Health Services Permit Agency|§ 20-8-103. Health Services Permit Commission — Powers and duties

 (a) The Health Services Permit Commission shall evaluate the availability and adequacy of health facilities and health services as they relate to long-term care facilities and home healthcare service agencies in this state.  (b) The commission shall designate those locales or areas of the state in which, due to the requirements of the population or the geography of the area, the health service needs of the population are underserved.  (c) The commission may specify, within locales or areas, categories of health services which are underserved or overserved due to the composition or requirements of the population or the geography of the area.  (d) The commission shall develop policies and adopt criteria, including time limitations, to be utilized by the Health Services Permit Agency in the review of applications and the issuing of permits of approval for a long-term care facility or a home healthcare service agency as provided in this subchapter.  (e) The commission may define certain underserved locales or areas or categories of services within underserved locales or areas to be exempt for specified periods of time from the permit-of-approval requirement.  (f) The commission may set application fees for permit-of-approval applications to be charged and collected by the agency.  (g)  (1) Upon appeal by the applicant or an interested party, the commission shall conduct hearings on decisions by the agency within ninety (90) days of the agency decision. The commission shall render its final decision within fifteen (15) days of the close of the hearing. Failure of the commission to take final action within these time periods shall be considered a ratification of the agency decision and shall constitute the final decision of the commission from which an appeal to circuit court may be filed.  (2) Neither a competitor of a successful applicant for a permit of approval nor any other party shall have the right to appeal the commission's decision to grant a permit of approval.
AR Code § 20-8-104 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 8 - State Health Agencies and Programs|Subchapter 1 - Health Services Permit Agency|§ 20-8-104. Health Services Permit Agency — Powers and duties

 (a) There is created and established the Health Services Permit Agency, which shall be under the supervision and control of the Department of Health.  (b) The agency, under the administration of the department, shall possess and exercise such duties and powers as necessary to implement the policy and procedures adopted by the Health Services Permit Commission.  (c) The agency, under the administration of the department, shall review all applications for permits of approval and approve or deny the application within ninety (90) days from the date the application is deemed complete and submitted for review.  (d) The State of Arkansas shall not participate in the capital expenditures review program, otherwise known as the “1122 Program”, unless it becomes mandatory for continuation in federal programs authorized under Title V of the Social Security Act, 42 U.S.C. § 701 et seq., Title XIV of the Social Security Act, 42 U.S.C. § 1351 et seq., and Title XVII of the Social Security Act, 42 U.S.C. § 1391 et seq., for all states.  (e) The agency, under the administration of the department, shall assist the commission in the performance of its duties under this subchapter.
AR Code § 20-8-105 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 8 - State Health Agencies and Programs|Subchapter 1 - Health Services Permit Agency|§ 20-8-105. Director

 (a) There shall be a Director of the Health Services Permit Agency, who shall be the executive head of the Health Services Permit Agency.  (b) The director shall be appointed by the Governor, subject to confirmation by the Senate, and shall serve at the pleasure of the Governor.  (c) The director shall report to the Secretary of the Department of Health.
AR Code § 20-8-107 (2020)
2020 Arkansas Code|Title 20 - Public Health and Welfare|Subtitle 2 - Health and Safety|Chapter 8 - State Health Agencies and Programs|Subchapter 1 - Health Services Permit Agency|§ 20-8-107. Expansion of facilities or services

 (a) Unless otherwise provided in this subchapter, all health facilities seeking to add new beds or home health services or to expand existing bed capacity or home health services shall apply for a permit approving additional beds or services or expanded bed capacity or services pursuant to procedures and criteria promulgated by the Health Services Permit Commission.  (b) The commission may authorize the Health Services Permit Agency to enjoin construction or expansion of existing facilities of any project commenced in violation of this subchapter through an action filed in the circuit court of the judicial district in which the project is located.  (c) In no event shall the requirements of this subchapter apply to any facility licensed or approved as of March 1, 2003, by the Child Welfare Agency Review Board pursuant to the Child Welfare Agency Licensing Act, § 9-28-401 et seq., and as specifically exempted by § 9-28-407(a)(3).  (d) Beginning July 1, 2005, the Health Services Permit Agency may not accept applications or requests for permits of approval to add new beds or to expand existing bed capacity of residential care facilities.